CARDINAL HEALTH ($CAH) posted quarterly earnings results for Q3 2026 on Thursday, April 30th. The company reported earnings of $3.17 per share, beating estimates of $2.82 by $0.35. The company also reported revenue of $60,940,000,000, missing estimates of $62,290,398,700 by $-1,350,398,700.
You can see Quiver Quantitative's $CAH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CARDINAL HEALTH Insider Trading Activity
CARDINAL HEALTH insiders have traded $CAH stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CAH stock by insiders over the last 6 months:
- AARON E ALT (Chief Financial Officer) sold 2,328 shares for an estimated $524,964
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
CARDINAL HEALTH Hedge Fund Activity
We have seen 658 institutional investors add shares of CARDINAL HEALTH stock to their portfolio, and 588 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 7,746,239 shares (-77.0%) from their portfolio in Q4 2025, for an estimated $1,591,852,114
- WCM INVESTMENT MANAGEMENT, LLC added 4,032,682 shares (+inf%) to their portfolio in Q4 2025, for an estimated $828,716,151
- BLACKROCK, INC. removed 2,823,035 shares (-9.0%) from their portfolio in Q4 2025, for an estimated $580,133,692
- MILLENNIUM MANAGEMENT LLC removed 1,580,019 shares (-79.6%) from their portfolio in Q4 2025, for an estimated $324,693,904
- HOLOCENE ADVISORS, LP removed 936,677 shares (-48.6%) from their portfolio in Q4 2025, for an estimated $192,487,123
- CITADEL ADVISORS LLC added 934,750 shares (+99.2%) to their portfolio in Q4 2025, for an estimated $192,091,125
- INVESCO LTD. removed 898,506 shares (-25.8%) from their portfolio in Q4 2025, for an estimated $184,642,983
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
CARDINAL HEALTH Government Contracts
We have seen $206,332,157 of award payments to $CAH over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- EXPRESS REPORT: MEDICAL SURGICAL PRIME VENDOR EXPENDITURES FOR THE MONTH OF APRIL 2025.: $10,194,510
- EXPRESS REPORT: MSPV EXPENDITURES FOR MAY 2025: $4,117,385
- 8511684196!OTHER MEDICAL: $1,300,000
- 4569286447!TRBO REGION 1: $1,268,080
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
CARDINAL HEALTH Analyst Ratings
Wall Street analysts have issued reports on $CAH in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 04/28/2026
- Morgan Stanley issued a "Overweight" rating on 01/29/2026
- Mizuho issued a "Outperform" rating on 11/04/2025
- TD Cowen issued a "Buy" rating on 11/03/2025
To track analyst ratings and price targets for CARDINAL HEALTH, check out Quiver Quantitative's $CAH forecast page.
CARDINAL HEALTH Price Targets
Multiple analysts have issued price targets for $CAH recently. We have seen 8 analysts offer price targets for $CAH in the last 6 months, with a median target of $243.5.
Here are some recent targets:
- Elizabeth Anderson from Evercore ISI Group set a target price of $240.0 on 04/08/2026
- Glen Santangelo from Barclays set a target price of $258.0 on 02/24/2026
- Stephen Baxter from Wells Fargo set a target price of $256.0 on 02/10/2026
- Lisa Gill from JP Morgan set a target price of $243.0 on 02/10/2026
- Steven Valiquette from Mizuho set a target price of $235.0 on 02/06/2026
- Erin Wright from Morgan Stanley set a target price of $245.0 on 01/29/2026
- Daniel Grosslight from Citigroup set a target price of $244.0 on 01/09/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
